Shenyu Ningshen Tablets
Shenyu Ningshen TabletsForMild to moderate depression with TCM syndrome differentiation of deficiency of both qi and yinThe treatment, is the company's independent research and development of traditional Chinese medicine 1.1 class of innovative drugs, the Ministry of Science and Technology"Thirteen Five"Major new drug creation-science and technology major special projects.
Based on the drug development process, the company has applied for and owns 2 invention patents (1 domestic and 1 Australian).
The results of the mechanism study show that:
① Shenyu Ningshen tablets can play an antidepressant effect by acting on the NE (norepinephrine) energy system, blocking the reuptake of monoamine neurotransmitters such as central 5-HT (5-hydroxytryptamine), and increasing 5-HT.
② Shenyu Ningshen tablets can effectively reverse the stress-induced increase of TLR4,MyD88 protein in hippocampus and serum inflammatory factors IL-1β,TNF-α content, and decrease of serum IL-10 content, so as to reduce the inflammatory cascade reaction by relying on MyD88 pathway, and then exert antidepressant effect.
Shenyu Ningshen tablets are effective, safe and reliable.
Phase III clinical results show that Shenyu Ningshen tablets are equivalent to fluoxetine in terms of efficacy and placebo in terms of safety; its listing provides a new treatment option for patients with depression.
Sweep, pay attention to us
Quick Navigation
Product Series
Contact Us
Address: Building 2, 66 Shengde Road, Tongzhou Bay River-Sea Linkage Development Demonstration Zone, Jiangsu Province
